Other studies have shown that the SARS-CoV-2 virus has had and will have a potentially damaging effect on the ovarian structure because COVID-19 disease is an independent risk factor in terms of ovarian function as a result of hormonal changes (levels of the anti-Mullerian hormone, testosterone, and prolactin) [30,31], the “immune/inflammatory distortion” caused by SARS-CoV-2, and because of the lack of access to doctors for surgical interventions during the pandemic of women diagnosed with ovarian tumor formations [31]. Here, PRL is linked to ovarian neoplasm.